ARCHIVES

Other NCI funding opportunities listed.

This article is from The Cancer Letter archive.

Vol. 30 No. 28 | July 9, 2004

Download PDF Visit The Full Archive

Related Articles

“If We Had More Resources, It’s A Fantastic Time” For Cancer Research

May 12, 1995

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

In Brief: Final appropriations for NCI Still Probably $875 Million; US-USR Drug Book Available

July 1, 1977

FDA Lists Therapies being Tested For AIDS, Opportunistic Infections

January 24, 1992

Cancer Control Dilemma: What To do With Successful Demonstrations

September 10, 1976

In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative”

August 11, 1989